Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date-Reference-Cited by-同舟云学术

Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date

Published:2021-06 Issue: Volume:Volume 15 Page:2815-2830
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Stancil Stephani L,Mirzayev Fuad,Abdel-Rahman Susan M

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference83 articles.

1. Global tuberculosis report. Geneva, Switzerland: World Health Organization; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf. Accessed March 15, 2021.

2. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

3. Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid

4. An overview of new antitubercular drugs, drug candidates, and their targets

5. Nitroimidazole-containing compounds and their antibacterial and antitubercular activities

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis;International Journal of Pharmaceutics;2024-10

2. Therapeutic drug monitoring in tuberculosis;European Journal of Clinical Pharmacology;2024-09-06

3. Intracellular peroxynitrite perturbs redox balance, bioenergetics, and Fe–S cluster homeostasis in Mycobacterium tuberculosis;Redox Biology;2024-09

4. In Silico Approach for Developing New Anti-Tuberculosis Drug Candidates: 3D-QSAR, Molecular Docking and ADME Studies of Pretomanid Derivatives;PHYS CHEM RES;2024

5. CRISPR Screening and Comparative LC‐MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis;Advanced Science;2024-08-20